Alternatives and similar repositories for indications:

Users that are interested in indications are comparing it to the libraries listed below

• dhimmel / integrate
  Scripts and resources to create Hetionet v1.0, a heterogeneous network for drug repurposing
  ☆32Updated 7 years ago
• adam-sam-brown / repoDB
  A Standard Database for Drug Repositioning
  ☆18Updated 7 years ago
• dhimmel / clintrials
  Cataloging pharmacotherapies in clinical trial from ClinicalTrials.gov
  ☆27Updated 8 years ago
• dhimmel / lincs
  Library of Integrated Cellular Signatures L1000
  ☆30Updated 2 years ago
• NeilPearson-Lilly / TractaViewer
  ☆11Updated 5 years ago
• SuLab / DrugMechDB
  A database of paths that represent the mechanism of action from a drug to a disease in an indication.
  ☆58Updated last year
• PathwayMerger / PathMe
  Harmonizing pathway databases using Biological Expression Language (BEL)
  ☆19Updated 7 months ago
• kgayvert / PrOCTOR
  A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials
  ☆18Updated 5 years ago
• MaayanLab / SEP-L1000
  Website for visualizing predicted drug side-effects using L1000 data (http://maayanlab.net/SEP-L1000/)
  ☆10Updated 2 years ago
• biopragmatics / bioversions
  🪝 What's the latest version for each database?
  ☆27Updated this week
• bio2bel / drugbank
  A Bio2BEL package for DrugBank (https://www.drugbank.ca)
  ☆9Updated 4 years ago
• varnivey / ipanda
  insilico Pathway Activation Network Decomposition Analysis (iPANDA) package. Owned by Insilico Medicine Inc. iPANDA is a pathway analysis…
  ☆25Updated 7 years ago
• Orphanet / Orphadata_aggregated
  Provided files are a partial extraction of the Orphanet knowledge base on Rare Diseases
  ☆45Updated 2 months ago
• NCIP / pathway-interaction-database
  The Pathway Interaction Database (PID) is software supporting the access and display of information about bio-molecular interactions and …
  ☆15Updated 9 years ago
• tatonetti-lab / onsides
  A resource of adverse drug effects extracted from FDA structured product labels
  ☆68Updated 2 weeks ago
• mickaelleclercq / BioDiscML
  Large-scale automatic feature selection for biomarker discovery in high-dimensional OMICs data
  ☆28Updated 10 months ago
• EBISPOT / efo
  Github repo for the Experimental Factor Ontology (EFO)
  ☆58Updated this week
• bio-ontology-research-group / multi-drug-embedding
  Method for drug repurposing from knowledge graphs and literature
  ☆34Updated 4 years ago
• chembl / tractability_pipeline_v2
  Pipeline for assessing the tractability of potential targets (starting from Gene IDs)
  ☆21Updated last week
• RTXteam / RTX
  Software repo for Team Expander Agent (Oregon State U., Institute for Systems Biology, and Penn State U.)
  ☆33Updated last week
• emreg00 / proximity
  Drug-disease proximity based therapeutic effect screening and analysis
  ☆19Updated 7 years ago
• GuiltyTargets / guiltytargets
  Target prioritization using network representation learning
  ☆11Updated 3 years ago
• ChengF-Lab / 2019-nCoV
  Network-based Drug Repurposing for Human Coronavirus
  ☆40Updated 5 years ago
• cssblab / iOmicsPASS
  Data Integration tool utilizing network information for predictive analyses
  ☆16Updated last year
• NCBI-Hackathons / drugdisco
  A high throughput automated drug discovery pipeline.
  ☆29Updated 6 years ago
• opentargets / OnToma
  Map your disease and phenotype terms to the Open Targets platform ontology
  ☆21Updated 3 months ago
• enricoferrero / TargetPred
  In Silico Prediction of Novel Therapeutic Targets Using Gene – Disease Association Data
  ☆18Updated 7 years ago
• labsyspharm / smallmoleculesuite-old
  ☆15Updated last year
• menchelab / MultiOme
  Network-based project to explore gene connectivity through biological scales
  ☆23Updated 4 months ago
• Barabasi-Lab / COVID-19
  Supplementary code for the paper: Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
  ☆27Updated 3 years ago